Dr. Holmes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3555 Round Barn Cir
Santa Rosa, CA 95403Phone+1 707-528-1050Fax+1 707-525-3874
Summary
- Jarrod Holmes, MD is an Oncologist based in Santa Rosa, CA, specializing in Breast Cancer and Hematologic Oncology. He completed his residency and internship in internal medicine at Naval Medical Center, San Diego, before pursuing a fellowship in hematology and medical oncology at the National Capital Consortium. Dr. Holmes graduated from Duke University School of Medicine in 2000. He is experienced in managing conditions such as thrombocytopenia, medical oncology, general/benign hematology, and leukopenia. His publications cover a range of topics in oncology and hematology and have been cited on multiple occasions in other professional writings.
Education & Training
- National Capital ConsortiumFellowship, Hematology and Medical Oncology, 2004 - 2007
- Naval Medical Center (San Diego)Residency, Internal Medicine, 2001 - 2003
- Naval Medical Center (San Diego)Internship, Internal Medicine, 2000 - 2001
- Duke University School of MedicineClass of 2000
Certifications & Licensure
- CA State Medical License 2008 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 165 citationsFinal report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer pat...Elizabeth A. Mittendorf, Guy T. Clifton, JP Holmes, Erika J Schneble, D. A. Van Echo
Annals of Oncology. 2014-09-01 - 33 citationsThe GP2 peptide: A HER2/neu-based breast cancer vaccineKevin S. Clive, Josh Tyler, G. Travis Clifton, Jarrod P. Holmes, Sathibalan Ponniah
Journal of Surgical Oncology. 2012-04-01 - 96 citationsThe Impact of HER2/neu Expression Level on Response to the E75 Vaccine: From U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02Linda C. Benavides, Jeremy D. Gates, M. G. Carmichael, Ritesh Patel, Jarrod P. Holmes
Clinical Cancer Research. 2009-04-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: